Logo image of IOM.CA

Assure Holdings Corp (IOM.CA) Stock Fundamental Analysis

TSX-V:IOM - TSX Venture Exchange - Common Stock

5.4  -0.45 (-7.69%)

Fundamental Rating

2

IOM gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 16 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of IOM have multiple concerns. While showing a medium growth rate, IOM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

IOM had negative earnings in the past year.
IOM.CA Yearly Net Income VS EBIT VS OCF VS FCFIOM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 -5M -10M -15M

1.2 Ratios

Industry RankSector Rank
ROA -7.01%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IOM.CA Yearly ROA, ROE, ROICIOM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 50 -50 -100 -150 -200

1.3 Margins

Industry RankSector Rank
OM -14.47%
PM (TTM) -10.87%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IOM.CA Yearly Profit, Operating, Gross MarginsIOM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 -100 -200 -300 -400

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for IOM has been increased compared to 1 year ago.
Compared to 1 year ago, IOM has a worse debt to assets ratio.
IOM.CA Yearly Shares OutstandingIOM.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 10M 20M 30M
IOM.CA Yearly Total Debt VS Total AssetsIOM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 10M 20M 30M 40M

2.2 Solvency

IOM has an Altman-Z score of 2.74. This is not the best score and indicates that IOM is in the grey zone with still only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.48 indicates that IOM is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z 2.74
ROIC/WACCN/A
WACCN/A
IOM.CA Yearly LT Debt VS Equity VS FCFIOM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 9.98 indicates that IOM has no problem at all paying its short term obligations.
IOM has a Quick Ratio of 9.98. This indicates that IOM is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 9.98
Quick Ratio 9.98
IOM.CA Yearly Current Assets VS Current LiabilitesIOM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 10M 20M 30M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.15% over the past year.
IOM shows a strong growth in Revenue. In the last year, the Revenue has grown by 66.81%.
Measured over the past years, IOM shows a very negative growth in Revenue. The Revenue has been decreasing by -39.35% on average per year.
EPS 1Y (TTM)87.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.14%
Revenue 1Y (TTM)66.81%
Revenue growth 3Y-39.35%
Revenue growth 5YN/A
Sales Q2Q%115.64%

3.2 Future

Based on estimates for the next years, IOM will show a very strong growth in Earnings Per Share. The EPS will grow by 20.20% on average per year.
The Revenue is expected to grow by 187.35% on average over the next years. This is a very strong growth
EPS Next Y100.26%
EPS Next 2Y42.69%
EPS Next 3Y27.8%
EPS Next 5Y20.2%
Revenue Next Year639.87%
Revenue Next 2Y232.75%
Revenue Next 3Y201%
Revenue Next 5Y187.35%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IOM.CA Yearly Revenue VS EstimatesIOM.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
IOM.CA Yearly EPS VS EstimatesIOM.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 0 -1 -2 -3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

IOM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 36.70 indicates a quite expensive valuation of IOM.
IOM's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.81.
Industry RankSector Rank
PE N/A
Fwd PE 36.7
IOM.CA Price Earnings VS Forward Price EarningsIOM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -21.62
IOM.CA Per share dataIOM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

IOM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IOM's earnings are expected to grow with 27.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.69%
EPS Next 3Y27.8%

More info and screens

0

5. Dividend

5.1 Amount

IOM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Assure Holdings Corp

TSX-V:IOM (1/31/2022, 7:00:00 PM)

5.4

-0.45 (-7.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.02%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap63.93M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 36.7
P/S 1.97
P/FCF N/A
P/OCF N/A
P/B 2.08
P/tB N/A
EV/EBITDA -21.62
EPS(TTM)-4.1
EYN/A
EPS(NY)0.15
Fwd EY2.72%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.73
BVpS2.6
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.01%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -14.47%
PM (TTM) -10.87%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.98
Quick Ratio 9.98
Altman-Z 2.74
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.14%
EPS Next Y100.26%
EPS Next 2Y42.69%
EPS Next 3Y27.8%
EPS Next 5Y20.2%
Revenue 1Y (TTM)66.81%
Revenue growth 3Y-39.35%
Revenue growth 5YN/A
Sales Q2Q%115.64%
Revenue Next Year639.87%
Revenue Next 2Y232.75%
Revenue Next 3Y201%
Revenue Next 5Y187.35%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A